The peptide still works its just measurably less efficient
hypothesized the central role of acrolein in the disruption of the structure of cell membranes in RBCs (changes in the cell membrane, cytosolic proteins, and osmotic sensitivity)
This demonstrates how genetic screening can reduce the risk of liver injury while minimizing unnecessary exclusions of potential patients [81]
doi: 10.1039/d2ra07673j
10.3389/fimmu.2023.1086078 Summary Keywords gut microbiota, metabolite, immune, NAFLD, NASH, botanical drug Citation Zhang Y, Liu L, Song R, Qu Z, Wang T, Liang L, Wang S, Zhang S, Li H and Wang H (2025) Potential mechanisms of natural metabolites and botanical drugs foumulae for the treatment of non-alcoholic fatty liver disease: targeting the gut microbiota to modulate the immune system